KYODO NEWS IMAGELINK

報道写真の購入なら共同通信イメージリンク

お問い合わせ
03-6252-6224
平日9:30-18:00

「血管収縮」の写真・グラフィックス・映像

絞り込み
  • 提供元
  • 日付
  • 種類
  • 向き
  • カテゴリ
  • 色
  • 同義語オン
  • 提供元
    • 共同通信社
      0
    • 国内提供元
      0
    • 海外提供元
      0
  • 日付
    • 24時間以内
      0
    • 48時間以内
      0
    • 72時間以内
      0
    • 7日以内
      0
    • 30日以内
      0
    • 1年以内
      0
    • 期間を指定
      18
    • 日付指定なし
      18
  • 種類
    • 写真
      18
    • グラフィックス
      0
    • 映像
      0
  • 向き
    • 縦
      3
    • 横
      15
    • 正方形
      0
  • カテゴリ
    • ニュース
    • スポーツ
    • エンターテインメント
    • 教育向け
      • カテゴリ指定なし
  • 色
    • カラー
      18
    • モノクロ
      0
  • 同義語辞書
    • オン
    • オフ
並び順
  • 古い順
18 件
( 1 ～ 18 件を表示)
  • 1
18 件
( 1 ～ 18 件を表示)
絞り込み
並び順
  • 古い順
  • The Medicines Safety Agency Warns About Cold Treatments - Paris
    2023年10月23日
    The Medicines Safety Agency Warns About Cold Treatments - Paris

    Illustration of boxes of Humex, Rhinadvil, Actifed and Dolirhume medicines in a Paris pharmacy on October 23, 2023. The French Drug Safety Agency warns about cold treatments. Infarctions and strokes can occur after using these pseudoephedrine-based vasoconstrictors, designed to relieve cold symptoms. The risk is low, but sufficient to advise against their prescription. Photo by Tomas Stevens/ABACAPRESS.COM、クレジット：Ｓｔｅｖｅｎｓ　Ｔｏｍａｓ／ＡＢＡＣＡ／共同通信イメージズ

    商品コード: 2023102400181

  • The Medicines Safety Agency Warns About Cold Treatments - Paris
    2023年10月23日
    The Medicines Safety Agency Warns About Cold Treatments - Paris

    Illustration of boxes of Humex, Rhinadvil, Actifed and Dolirhume medicines in a Paris pharmacy on October 23, 2023. The French Drug Safety Agency warns about cold treatments. Infarctions and strokes can occur after using these pseudoephedrine-based vasoconstrictors, designed to relieve cold symptoms. The risk is low, but sufficient to advise against their prescription. Photo by Tomas Stevens/ABACAPRESS.COM、クレジット：Ｓｔｅｖｅｎｓ　Ｔｏｍａｓ／ＡＢＡＣＡ／共同通信イメージズ

    商品コード: 2023102400189

  • The Medicines Safety Agency Warns About Cold Treatments - Paris
    2023年10月23日
    The Medicines Safety Agency Warns About Cold Treatments - Paris

    Illustration of boxes of Humex, Rhinadvil, Actifed and Dolirhume medicines in a Paris pharmacy on October 23, 2023. The French Drug Safety Agency warns about cold treatments. Infarctions and strokes can occur after using these pseudoephedrine-based vasoconstrictors, designed to relieve cold symptoms. The risk is low, but sufficient to advise against their prescription. Photo by Tomas Stevens/ABACAPRESS.COM、クレジット：Ｓｔｅｖｅｎｓ　Ｔｏｍａｓ／ＡＢＡＣＡ／共同通信イメージズ

    商品コード: 2023102400179

  • The Medicines Safety Agency Warns About Cold Treatments - Paris
    2023年10月23日
    The Medicines Safety Agency Warns About Cold Treatments - Paris

    Illustration of boxes of Humex, Rhinadvil, Actifed and Dolirhume medicines in a Paris pharmacy on October 23, 2023. The French Drug Safety Agency warns about cold treatments. Infarctions and strokes can occur after using these pseudoephedrine-based vasoconstrictors, designed to relieve cold symptoms. The risk is low, but sufficient to advise against their prescription. Photo by Tomas Stevens/ABACAPRESS.COM、クレジット：Ｓｔｅｖｅｎｓ　Ｔｏｍａｓ／ＡＢＡＣＡ／共同通信イメージズ

    商品コード: 2023102400268

  • The Medicines Safety Agency Warns About Cold Treatments - Paris
    2023年10月23日
    The Medicines Safety Agency Warns About Cold Treatments - Paris

    Illustration of boxes of Humex, Rhinadvil, Actifed and Dolirhume medicines in a Paris pharmacy on October 23, 2023. The French Drug Safety Agency warns about cold treatments. Infarctions and strokes can occur after using these pseudoephedrine-based vasoconstrictors, designed to relieve cold symptoms. The risk is low, but sufficient to advise against their prescription. Photo by Tomas Stevens/ABACAPRESS.COM、クレジット：Ｓｔｅｖｅｎｓ　Ｔｏｍａｓ／ＡＢＡＣＡ／共同通信イメージズ

    商品コード: 2023102400269

  • The Medicines Safety Agency Warns About Cold Treatments - Paris
    2023年10月23日
    The Medicines Safety Agency Warns About Cold Treatments - Paris

    Illustration of boxes of Humex, Rhinadvil, Actifed and Dolirhume medicines in a Paris pharmacy on October 23, 2023. The French Drug Safety Agency warns about cold treatments. Infarctions and strokes can occur after using these pseudoephedrine-based vasoconstrictors, designed to relieve cold symptoms. The risk is low, but sufficient to advise against their prescription. Photo by Tomas Stevens/ABACAPRESS.COM、クレジット：Ｓｔｅｖｅｎｓ　Ｔｏｍａｓ／ＡＢＡＣＡ／共同通信イメージズ

    商品コード: 2023102400270

  • The Medicines Safety Agency Warns About Cold Treatments - Paris
    2023年10月23日
    The Medicines Safety Agency Warns About Cold Treatments - Paris

    Illustration of boxes of Humex, Rhinadvil, Actifed and Dolirhume medicines in a Paris pharmacy on October 23, 2023. The French Drug Safety Agency warns about cold treatments. Infarctions and strokes can occur after using these pseudoephedrine-based vasoconstrictors, designed to relieve cold symptoms. The risk is low, but sufficient to advise against their prescription. Photo by Tomas Stevens/ABACAPRESS.COM、クレジット：Ｓｔｅｖｅｎｓ　Ｔｏｍａｓ／ＡＢＡＣＡ／共同通信イメージズ

    商品コード: 2023102400320

  • The Medicines Safety Agency Warns About Cold Treatments - Paris
    2023年10月23日
    The Medicines Safety Agency Warns About Cold Treatments - Paris

    Illustration of boxes of Humex, Rhinadvil, Actifed and Dolirhume medicines in a Paris pharmacy on October 23, 2023. The French Drug Safety Agency warns about cold treatments. Infarctions and strokes can occur after using these pseudoephedrine-based vasoconstrictors, designed to relieve cold symptoms. The risk is low, but sufficient to advise against their prescription. Photo by Tomas Stevens/ABACAPRESS.COM、クレジット：Ｓｔｅｖｅｎｓ　Ｔｏｍａｓ／ＡＢＡＣＡ／共同通信イメージズ

    商品コード: 2023102400319

  • The Medicines Safety Agency Warns About Cold Treatments - Paris
    2023年10月23日
    The Medicines Safety Agency Warns About Cold Treatments - Paris

    Illustration of boxes of Humex, Rhinadvil, Actifed and Dolirhume medicines in a Paris pharmacy on October 23, 2023. The French Drug Safety Agency warns about cold treatments. Infarctions and strokes can occur after using these pseudoephedrine-based vasoconstrictors, designed to relieve cold symptoms. The risk is low, but sufficient to advise against their prescription. Photo by Tomas Stevens/ABACAPRESS.COM、クレジット：Ｓｔｅｖｅｎｓ　Ｔｏｍａｓ／ＡＢＡＣＡ／共同通信イメージズ

    商品コード: 2023102400322

  • The Medicines Safety Agency Warns About Cold Treatments - Paris
    2023年10月23日
    The Medicines Safety Agency Warns About Cold Treatments - Paris

    Illustration of boxes of Humex, Rhinadvil, Actifed and Dolirhume medicines in a Paris pharmacy on October 23, 2023. The French Drug Safety Agency warns about cold treatments. Infarctions and strokes can occur after using these pseudoephedrine-based vasoconstrictors, designed to relieve cold symptoms. The risk is low, but sufficient to advise against their prescription. Photo by Tomas Stevens/ABACAPRESS.COM、クレジット：Ｓｔｅｖｅｎｓ　Ｔｏｍａｓ／ＡＢＡＣＡ／共同通信イメージズ

    商品コード: 2023102400318

  • The Medicines Safety Agency Warns About Cold Treatments - Paris
    2023年10月23日
    The Medicines Safety Agency Warns About Cold Treatments - Paris

    Illustration of boxes of Humex, Rhinadvil, Actifed and Dolirhume medicines in a Paris pharmacy on October 23, 2023. The French Drug Safety Agency warns about cold treatments. Infarctions and strokes can occur after using these pseudoephedrine-based vasoconstrictors, designed to relieve cold symptoms. The risk is low, but sufficient to advise against their prescription. Photo by Tomas Stevens/ABACAPRESS.COM、クレジット：Ｓｔｅｖｅｎｓ　Ｔｏｍａｓ／ＡＢＡＣＡ／共同通信イメージズ

    商品コード: 2023102400385

  • The Medicines Safety Agency Warns About Cold Treatments - Paris
    2023年10月23日
    The Medicines Safety Agency Warns About Cold Treatments - Paris

    Illustration of boxes of Humex, Rhinadvil, Actifed and Dolirhume medicines in a Paris pharmacy on October 23, 2023. The French Drug Safety Agency warns about cold treatments. Infarctions and strokes can occur after using these pseudoephedrine-based vasoconstrictors, designed to relieve cold symptoms. The risk is low, but sufficient to advise against their prescription. Photo by Tomas Stevens/ABACAPRESS.COM、クレジット：Ｓｔｅｖｅｎｓ　Ｔｏｍａｓ／ＡＢＡＣＡ／共同通信イメージズ

    商品コード: 2023102400392

  • The Medicines Safety Agency Warns About Cold Treatments - Paris
    2023年10月23日
    The Medicines Safety Agency Warns About Cold Treatments - Paris

    Illustration of boxes of Humex, Rhinadvil, Actifed and Dolirhume medicines in a Paris pharmacy on October 23, 2023. The French Drug Safety Agency warns about cold treatments. Infarctions and strokes can occur after using these pseudoephedrine-based vasoconstrictors, designed to relieve cold symptoms. The risk is low, but sufficient to advise against their prescription. Photo by Tomas Stevens/ABACAPRESS.COM、クレジット：Ｓｔｅｖｅｎｓ　Ｔｏｍａｓ／ＡＢＡＣＡ／共同通信イメージズ

    商品コード: 2023102400386

  • The Medicines Safety Agency Warns About Cold Treatments - Paris
    2023年10月23日
    The Medicines Safety Agency Warns About Cold Treatments - Paris

    Illustration of boxes of Humex, Rhinadvil, Actifed and Dolirhume medicines in a Paris pharmacy on October 23, 2023. The French Drug Safety Agency warns about cold treatments. Infarctions and strokes can occur after using these pseudoephedrine-based vasoconstrictors, designed to relieve cold symptoms. The risk is low, but sufficient to advise against their prescription. Photo by Tomas Stevens/ABACAPRESS.COM、クレジット：Ｓｔｅｖｅｎｓ　Ｔｏｍａｓ／ＡＢＡＣＡ／共同通信イメージズ

    商品コード: 2023102400569

  • The Medicines Safety Agency Warns About Cold Treatments - Paris
    2023年10月23日
    The Medicines Safety Agency Warns About Cold Treatments - Paris

    Illustration of boxes of Humex, Rhinadvil, Actifed and Dolirhume medicines in a Paris pharmacy on October 23, 2023. The French Drug Safety Agency warns about cold treatments. Infarctions and strokes can occur after using these pseudoephedrine-based vasoconstrictors, designed to relieve cold symptoms. The risk is low, but sufficient to advise against their prescription. Photo by Tomas Stevens/ABACAPRESS.COM、クレジット：Ｓｔｅｖｅｎｓ　Ｔｏｍａｓ／ＡＢＡＣＡ／共同通信イメージズ

    商品コード: 2023102400576

  • The Medicines Safety Agency Warns About Cold Treatments - Paris
    2023年10月23日
    The Medicines Safety Agency Warns About Cold Treatments - Paris

    Illustration of boxes of Humex, Rhinadvil, Actifed and Dolirhume medicines in a Paris pharmacy on October 23, 2023. The French Drug Safety Agency warns about cold treatments. Infarctions and strokes can occur after using these pseudoephedrine-based vasoconstrictors, designed to relieve cold symptoms. The risk is low, but sufficient to advise against their prescription. Photo by Tomas Stevens/ABACAPRESS.COM、クレジット：Ｓｔｅｖｅｎｓ　Ｔｏｍａｓ／ＡＢＡＣＡ／共同通信イメージズ

    商品コード: 2023102400578

  • The Medicines Safety Agency Warns About Cold Treatments - Paris
    2023年10月23日
    The Medicines Safety Agency Warns About Cold Treatments - Paris

    Illustration of boxes of Humex, Rhinadvil, Actifed and Dolirhume medicines in a Paris pharmacy on October 23, 2023. The French Drug Safety Agency warns about cold treatments. Infarctions and strokes can occur after using these pseudoephedrine-based vasoconstrictors, designed to relieve cold symptoms. The risk is low, but sufficient to advise against their prescription. Photo by Tomas Stevens/ABACAPRESS.COM、クレジット：Ｓｔｅｖｅｎｓ　Ｔｏｍａｓ／ＡＢＡＣＡ／共同通信イメージズ

    商品コード: 2023102400574

  • The Medicines Safety Agency Warns About Cold Treatments - Paris
    2023年10月23日
    The Medicines Safety Agency Warns About Cold Treatments - Paris

    Illustration of boxes of Humex, Rhinadvil, Actifed and Dolirhume medicines in a Paris pharmacy on October 23, 2023. The French Drug Safety Agency warns about cold treatments. Infarctions and strokes can occur after using these pseudoephedrine-based vasoconstrictors, designed to relieve cold symptoms. The risk is low, but sufficient to advise against their prescription. Photo by Tomas Stevens/ABACAPRESS.COM、クレジット：Ｓｔｅｖｅｎｓ　Ｔｏｍａｓ／ＡＢＡＣＡ／共同通信イメージズ

    商品コード: 2023102400620

  • 1
Copyright © KYODO NEWS IMAGES INC. All Rights Reserved.